IPI Legacy Liquidation Co (fka IMPLQ)

[The Night Stalker]

wow

[biotech_researcher]

Toast..

[The Night Stalker]

keeps bleeding why

[The Night Stalker]

nah

[The Night Stalker]

big dip

[napoleanrags]

Setting up nice

[biotech_researcher]

Looking fabulous

[biotech_researcher]

Impel Pharmaceuticals to Present Trudhesa® Data at the 64th Annual Meeting of the American Headache Society
Jun 09, 2022

PDF Version
Oral Presentation Showcases Early Ability to Predict Responders to Trudhesa

New Analysis Suggest Patient-Reported Benefits of Long-Term Use with Trudhesa

Two Additional Analyses Demonstrate Trudhesa Efficacy Regardless of Current Preventive Therapies or Prior Acute Treatments

[biotech_researcher]

Biohaven deal shifts target to Impel Pharma as a next likely target: @$35

https://seekingalpha.com/news/3838886-global-blood-impel-pharma-could-be-targets-after-biohaven-deal

[biotech_researcher]

Impel NeuroPharma Provides Updates on Trudhesa™ Launch and Recent Business Highlights
Jan 18, 2022

PDF Version
Trudhesa™ (Dihydroergotamine Mesylate) Nasal Spray for Acute Migraine Delivered Strong Q4 2021 Launch with 4,200 (TRx) Prescriptions; Exceeding Company’s Guidance Range

Achieved Broad and Favorable Trudhesa™ Payer Coverage with Signed Agreements Covering 80% of U.S. Commercial Lives

Planned Initiation of INP105 Proof-of-Concept Study for Autism Spectrum Disorder in Q1 2022; Results anticipated Q4 2022

https://investors.impelnp.com/news-releases/news-release-details/impel-neuropharma-provides-updates-trudhesatm-launch-and-recent/

[biotech_researcher]

23 million shares outstanding, 80% institutionally owned. FDA approved drug for migraines, with unique delivery mechanism for the nostrils. Only have 4 weeks of sales history in Q3 from approval, but it was robust. Q4 results we be pivotal event..

[biotech_researcher]

My favorite biotech. Totally unknown..

[Jake L]

IMPL - Friday Rundown, Monday Expectations

[Jake L]

IMPL - Thursday Rundown, Friday Expectations

[Jake L]

IMPL - The Run Starts

[Pedro2004]

Did anyone find-out what the scam was on Friday?

I'm going to guess they converted some debt into shares -- and they dumped the shares.

[makinezmoney]

$IMPL: Wow......... what a kerplunkage.


Down to $18.77


Shorts here today won............ they shoulda sold the top in the AM



GO $IMPL

[stock1ace1]

flipping now easy $ fast sto 1/2

[TheFinalCD]

34 to 19 how ugly

[TheFinalCD]

I sold those 29's for a profit, then didnt re-enter


im strugglin with a boat-load of ANY

[stock1ace1]

looks like the approval was already priced in

[stock1ace1]

$19.85 gotta love the markets :D may enter soon

[TheFinalCD]

in 29.23 on this big open dip

IMPL

[makinezmoney]

$IMPL: NIcely done......... now $35.80 here


FDA approval done !!!!!!




$IMPL Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA™ (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine


GO $IMPL

[crudeoil24]

Impel NeuroPharma Price Target Announced at $32.00/Share by Guggenheim



IMPL

[stocktrademan]

IMPL buy 10.90

This is the best stock where the ADX has entered the bullish "in transit" mode between the DI lines.

Bonus: Free unlimited scanner with perfect timing (the magic words that should always be said)
https://tos.mx/4Ue5OS5

As an augment, the chart shows remarkable MACD bullish divergence off the double bottom pattern...

https://finance.yahoo.com/quote/IMPL/profile?p=IMPL

https://www.barchart.com/stocks/quotes/IMPL

https://finviz.com/quote.ashx?t=IMPL

https://www.stockconsultant.com/consultnow/basicplus.cgi?symbol=IMPL

https://stockcharts.com/c-sc/sc?chart=IMPL,uu[e,a]dhclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20][iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!lf14][j20444984,y]&r=3555b

https://www.barchart.com/etfs-funds/quotes/IMPL/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=TREND&sym=IMPL&grid=1&height=500&studyheight=100&timeframe=2%20Months




normal chart









log chart









normal chart








log chart